Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma

Journal article

Peer reviewed

Edward J Gettings, Christopher T Hackett and Thomas F Scott

Multiple sclerosis, v 21(5), pp 670-670

Apr 2015

PMID: 25257614

Additional Links

Antibodies, Monoclonal - adverse effects

Antibodies, Monoclonal - therapeutic use

Antineoplastic Agents - adverse effects

Antineoplastic Agents - therapeutic use

Ataxia - etiology

Gait Disorders, Neurologic - etiology

Humans

Ipilimumab

Male

Melanoma - complications

Melanoma - drug therapy

Middle Aged

Multiple Sclerosis, Relapsing-Remitting - complications

Paresis - etiology

Recurrence

Treatment Outcome

9 Record Views

81 citations in Scopus

Title: Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma
Creators: Edward J Gettings - Allegheny General Hospital
Christopher T Hackett - Department of Neurology, Allegheny General Hospital, Pittsburgh, USA
Thomas F Scott - Allegheny General Hospital
Publication Details: Multiple sclerosis, v 21(5), pp 670-670
Publisher: Sage
Resource Type: Journal article
Language: English
Academic Unit: Neurology
Web of Science ID: WOS:000352165700021
Scopus ID: 2-s2.0-84952785505
Other Identifier: 991019167335704721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: